Grade: Pharmaceutical Grade

Factory Location: Lianyungang Jiangsu China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Mesna is an organosulfur compound. It is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy. These two anticancer agents, in vivo, may be converted to urotoxic metabolites, such as acrolein.
Mesna API gets Chinese local GMP certificate and US-DMF is available. EDMF is also submitted in schedule.
Mesna Injection gets Chinese local GMP certificate.